Advancement in radiation therapy after breast conserving surgery for patients with early breast cancer

doi:10.3877/cma.j.issn.1674-0793.2015.01.017

Abstract

Abstract:

Radiotherapy after breast-conserving surgery has become the major treatment for patients with invasive early stage breast cancer, which can effectively reduce the ipsilateral breast local recurrence, improve overall survival, preserve the physiological function of the breast and ameliorate the patients’ psychological needs. This article has comprehensively reviewed the advancement in clinical radiation biology in the approaches to deliver radiotherapy and regimens of different dose fraction.

Key words: Invasive breast cancer, Breast conserving surgery, Radiation therapy, Research progress

Yufeng Ren, Huanxin Lin, Bixiu Wen. Advancement in radiation therapy after breast conserving surgery for patients with early breast cancer[J]. Chinese Archives of General Surgery(Electronic Edition), 2015, 09(01): 67-70.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhptwkxwx.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0793.2015.01.017

https://zhptwkxwx.cma-cmc.com.cn/EN/Y2015/V09/I01/67

References 24

[1]	Wickberg A,Holmberg L,Adami HO, et al. Sector resection with or without postoperative radiotherapy for stage I breast cancer: 20-year results of a randomized trial[J]. J Clin Oncol, 2014, 32(8): 791-797.
[2]	Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials[J]. Lancet, 2011, 378(9804): 1707-1716.
[3]	Buchholz TA. Radiotherapy and survival in breast cancer[J]. Lancet, 2011, 378(9804): 1680-1682.
[4]	Fisher B,Wickerham DL,Deutsch M, et al. Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings[J]. Semin Surg Oncol, 1992, 8(3): 153-160.
[5]	Veronesi U,Saccozzi R,Del Vechio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast[J]. N Engl J Med, 1981, 305(1): 6-11.
[6]	Polgar C,Fodor J,Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma-5-year results of a randomized trial[J]. Int J Radiat Oncol Biol Phys, 2007, 69(3): 694-702.
[7]	Kim Y,Prada DS,Trombetta MG, et al. Dosimetric comparison of partial and whole breast external beam irradiation in the treatment of early stage breast cancer[J]. Med Phys, 2007, 34(12): 4640-4648.
[8]	Sethi RA,No HS,Jozsef G, et al. Comparison of three-dimensional versus intensity-modulated radiotherapy techniques to treat breast and axillary level III and supraclavicular nodes in a prone versus supine position[J]. Radiother Oncol, 2012, 102(1):74-81.
[9]	Hong L,Hunt M,Chui C, et al. Intensity-modulated tangential beam irradiation of the intact breast[J]. Int J Radiat Oncol Biol Phys, 1999, 44(5):1155-1164.
[10]	Haviland JS,Owen JR,Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials[J]. Lancet Oncol, 2013, 14(11): 1086-1094.
[11]	Bartelink H,Horiot JC,Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial[J]. J Clin Oncol, 2007, 25(22): 3259-3265.
[12]	Bahadur YA,Constantinescu CT. Tumor bed boost radiotherapy in breast cancer. A review of current techniques[J]. Saudi Med J, 2012, 33(4): 353-366.
[13]	Pan Q,Calitchi E,Otmezguine Y, et al. Long-term results of exclusive radiotherapy and brachytherapy of breast cancer[J]. Cancer Radiother, 2012, 16(8): 674-680.
[14]	van der Laan HP,Hurkmans CW,Kuten A, et al. Current technological clinical practice in breast radiotherapy, results of a survey in EORTC-Radiation Oncology Group affiliated institutions[J]. Radiother Oncol, 2010, 94(3): 280-285.
[15]	Hardee ME,Raza S,Becker SJ, et al. Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique[J]. Int J Radiat Oncol Biol Phys, 2012, 82(3): e415-423.
[16]	McDonald MW,Godette KD,Whitaker DJ, et al. Three-year outcomes of breast intensity-modulated radiation therapy with simultaneous integrated boost[J]. Int J Radiat Oncol Biol Phys, 2010, 77(2): 523-530.
[17]	Veronesi U,Marubini E,Mariani L, et al. Radiotherapy after breastconserving surgery in small breast carcinoma: long-term results of a randomized trial[J]. Ann Oncol, 2001, 12(7): 997-1003.
[18]	Vicini FA,Goldstein NS,Pass H, et al. Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy[J]. Int J Radiat Oncol Biol Phys, 2004, 60(1): 86-94.
[19]	Smith BD,Arthur DW,Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO)[J]. Int J Radiat Oncol Biol Phys, 2009, 209(2): 269-277.
[20]	Vicini F,Beitsch PD,Quiet CA, et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons Mammo Site Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI)[J]. Cancer, 2008, 112(4): 758-766.
[21]	Vaidya JS,Wenz F,Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomized trial[J]. Lancet, 2014, 383(9917): 603-613.
[22]	Moon SH,Shin KH,Kim TH, et al. Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy[J]. Radiother Oncol, 2009, 90(1): 66-73.
[23]	Wen B,Hsu H,Formenti-Ujlaki GF, et al. Prone accelerated partial breast irradiation after breast-conserving surgery: compliance to the dosimetry requirements of RTOG-0413[J]. Int J Radiat Oncol Biol Phys, 2012, 84 (4): 910-916.
[24]	Veronesi U,Orecchia R,Maisonneuve P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial[J]. Lancet Oncol, 2013, 14 (13): 1269-1277.

Please choose a citation manager

Content to export